Skip to main content
Make a Donation
Sign In
Industry
Membership
Search
AATS Online
Presentations
Guidelines
Surgical Videos
Experts Forum
Meetings/Webinars
Meetings
Annual Meeting
Past Annual Meetings
Webinars
Foundation
Overview
President's Message
Strategic Plan
Governance
Make a Donation
Industry Partners
Annual Reports
Publications
JTCVS
JTCVS Open
JTCVS Techniques
OpTechs
Seminars in Thoracic and Cardiovascular Surgery
The Pediatric Cardiac Surgery Annual
Newsletter
Communication Preferences
AATS Journal Alerts
Scholarships
Open Programs
Upcoming Programs
Reach of our Programs
Industry
Webinars
Resources
Affiliated Organizations
Lung Cancer Screening
Quality Gateway
Thoracic Surgery Oncology Group
About
President's Message
Strategic Plan
ByLaws and Policies
Governance
Newsroom
Contact Us
Careers
Membership
Overview
Application Process
Nominate a Candidate
Sponsorship Requirements
Member Directory
New Members
Committee Self-Nomination
2020 Business Meeting
Disclosure Portal
Loading
Thoracic Surgery Oncology Group
Joining the Network
Join the North American thoracic surgery clinical trials network, aiming to improve the understanding of thoracic oncologic diseases and enhance the care of patients. Following the success of the first RFA in 2017, the network is expanding to involve more institutions in its clinical trial portfolio of studies involving thoracic malignancies.
Funding for all operational, correlative studies, institutional review board review, research study assistant support, and local administrative support will be the responsibility of each site in conjunction with the principal investigator (PI) of the proposal. The AATS will provide limited administrative support for TSOG .
The primary goal will be on rapid accrual and successful completion of thoracic surgeon lead clinical trials. While clinical trials can address many different problems, the focus of TSOG will be on phase I/II studies, window of opportunity trials with correlative analyses, intraoperative imaging studies, relevant registry studies, and multidisciplinary study designs.
Current Request for Application Process
Given the limited administrative support/resources and the need to accrue patients rapidly for trial completion, we anticipate no more than four to six sites will be activated in this upcoming RFA. The process involves submission of the application no later than the deadline. Following selection, chosen programs will convene for a “state-of-the-science” meeting which includes discussion of potential trials which will be selected as the index TSOG trials.
The application deadline has passed, but please check back in the future for the next RFA.
TSOG Site Selection Criteria
High volume centers for thoracic oncologic procedures with an emphasis on lung, esophageal, and other thoracic malignancies
Evidence of site-specific financial sustainability and existing infrastructure for completion of clinical trials
Active participation of thoracic surgeons with expertise in oncologic clinical trial involvement and a history of robust accrual
Institutional Redcap software license
{1}
##LOC[OK]##
{1}
##LOC[OK]##
##LOC[Cancel]##
{1}
##LOC[OK]##
##LOC[Cancel]##